Kersten Geert R

Avg. Two Year Performance

(13%) Avg. Purchase Return
(6%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return20%26%15%(7%)(13%)
Purchase Success Rate10 of 248 of 249 of 246 of 244 of 24
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 1.2M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--